Hence, the anti-inflammatory effect of C66 in diabetes-associated renal impairment appears to be the result partially of the suppressed expression of VCAM-1, ICAM-1, and MCP-1 in the renal epithelium. This evidence concerns the gene ICAM1 and diabetes mellitus.